Skip to content
10-K

Annual Report

ASPEN AEROGELS INC ASPN

0000950170-25-029252

← back to feed
Filed
Feb 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 25, 2025 82.06M sh
Short Term Debt FY 2024 · Dec 31, 2024 $19.75M
Cash And Equivalents FY 2024 · Dec 31, 2023 $139.72M
Current Liabilities FY 2024 · Dec 31, 2023 $78.1M
Total Liabilities FY 2024 · Dec 31, 2023 $214.99M
Current Assets FY 2024 · Dec 31, 2023 $266.33M
Total Assets FY 2024 · Dec 31, 2023 $703.05M
Shares Diluted FY 2024 · Dec 31, 2022 39.36M sh
Capex FY 2024 · Dec 31, 2022 $177.97M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$94.4M
Eps Diluted FY 2024 · Dec 31, 2022 −$2.10
Eps Basic FY 2024 · Dec 31, 2022 −$2.10
Sga Expense FY 2024 · Dec 31, 2022 $38.5M
Rd Expense FY 2024 · Dec 31, 2022 $16.93M
Net Income FY 2024 · Dec 31, 2022 −$82.74M
Operating Income FY 2024 · Dec 31, 2022 −$79.25M
Gross Profit FY 2024 · Dec 31, 2022 $4.98M
Cost Of Revenue FY 2024 · Dec 31, 2022 $175.39M
Revenue FY 2024 · Dec 31, 2022 $180.36M
Stockholders Equity FY 2024 · Dec 31, 2021 $128.41M